Hello, I'm hoping to gain some clarity on the transition timeline for Annex XVI devices under the MDR. We're a US based company currently selling an aesthetic product in the EU, not subject to the MDD. Under the MDR, this would be considered a Annex XVI device, Class IIa. We currently have no MDD certificate or NB. We seem to be receiving conflicting reports regarding our timeline transition to the MDR. We've been told that without a NB issued CE certificate to the MDR, we will not be able to sell our devices in Europe after May 25th, 2020. However, Article 1(2) of the MDR states that the MDR will only apply to Annex XVI devices after Common Specifications are released, which come into force 6 months later. To our knowledge, no CS's are currently available. So, our ultimate question is: are we able to keep selling our device after May 26th, 2020, or do we need to halt EU sales? Thanks!